CDEK
← All drugs Report issue

inactivated SARS-Cov-2 vaccine

Vaccineexperimental

Clinical trial activity

41 trials · 41 clinical orgs · 0 marketing orgs

Phase 1
11
Phase 2
29
Phase 3
15
Phase 4
8

Earliest trial started Apr 13, 2020 (NCT04352608)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, active

    SARS-CoV-2 immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05952505Phase 4Aug 31, 2023China National Biotec Group Co., Ltd, Government of China
NCT05580159Phase 3Oct 31, 2022Government of Cambodia, Stemirna Therapeutics
NCT05216484Phase 3Feb 18, 2022Chinese Academy of Medical Sciences, Government of China
NCT05204589Phase 3Jan 22, 2022Government of China
NCT05156632Phase 3Jan 20, 2022Rehman Medical Institute, Sinovac Biotech Co., Ltd
NCT05163652Phase 3Dec 18, 2021Chinese Academy of Medical Sciences, Government of China
NCT05164731Phase 3Dec 16, 2021Chinese Academy of Medical Sciences, Government of China
NCT05067894Phase 1/Phase 2 (Phase 2)Nov 30, 2021Government of Indonesia, PT Bio Farma, University of Indonesia
NCT05238649Phase 2Nov 10, 2021Livzon Pharmaceutical Group Inc., Zhuhai People's Hospital Medical Group
NCT05003466Phase 2Sep 30, 2021Beijing Minhai Biotechnology Co., Ltd, Government of China, Shenzhen Kangtai Biological Products Co., LTD
NCT05035238Phase 2Sep 20, 2021Erciyes University, Government of Turkey, Kocak Farma, MENE Research
NCT05043259Phase 1/Phase 2 (Phase 2)Sep 13, 2021Government of China
NCT05003479Phase 1Aug 31, 2021Beijing Minhai Biotechnology Co., Ltd, Government of China, Shenzhen Kangtai Biological Products Co., LTD
NCT04952727Phase 4Aug 26, 2021Government of China, Tianjin Cansino Biotechnology Inc
NCT04992182Phase 2Jul 8, 2021Government of Chile, Pontificia Universidad Catolica de Chile, Universidad del Desarrollo, University of Chile
NCT04944381N/AJul 2, 2021Chinese Academy of Medical Sciences
NCT04962308Phase 4Jun 19, 2021Government of China, Sinovac Biotech Co., Ltd
NCT04852705Phase 3May 31, 2021Beijing Minhai Biotechnology Co., Ltd, Shenzhen Kangtai Biological Products Co., LTD
NCT04892459Phase 4May 25, 2021Government of China, Tianjin Cansino Biotechnology Inc
NCT04884685Phase 2May 3, 2021Government of China, Sinovac Biotech Co., Ltd
Showing 20 of 41 trials
Page 1 / 3

Organizations

Research & Development (41)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment21542020
Sinovac Biotech Co., LtdFor profit9832020
Chinese Academy of Medical SciencesAcademic/Hospital7732020
Beijing Minhai Biotechnology Co., LtdFor profit5232020
Shenzhen Kangtai Biological Products Co., LTDFor profit5332020
Butantan InstituteAcademic/Hospital4222020
China National Biotec Group Co., LtdFor profit3122020
Beijing Tiantan Bio Co., LtdFor profit2012020
China National Pharmaceutical GroupFor profit2012020
Government of ChileGovernment2022020
Government of IndonesiaGovernment2022020
Kocak FarmaFor profit2122021
Pontificia Universidad Catolica de ChileAcademic/Hospital2122020
PT Bio FarmaFor profit2222020
Sichuan UniversityAcademic/Hospital2012020
Tianjin Cansino Biotechnology IncFor profit2012021
Abu Dhabi Health Services CompanyAcademic/Hospital1012020
Cayetano Heredia UniversityAcademic/Hospital1112020
CEMEC Pesquisa ClinicaAcademic/Hospital1012020
D'Or Institute for Research and EducationAcademic/Hospital1112021
41 organizations
Page 1 / 3